Literature DB >> 22165673

Windows into estradiol effects in Alzheimer's disease therapy.

E M Mohamd1, H H Ahmed, S F Estefan, A E-R H Farrag, R S Salah.   

Abstract

BACKGROUND AND OBJECTIVES: Alzheimer's disease (AD) is a neurological disorder associated with aging. The neuropathologic features of this disease are senile plaques and neurofibrillary tangles, which are present in memory structures and cerebral cortex. This study focuses on evaluation of estradiol administration in the management of neurological changes accompanied with AD in ovariectomized rats intoxicated with aluminum.
MATERIALS AND METHODS: Fifty adult female rats were classified into 5 main groups as follows: Group (1): gonad intact control, Group (2): ovariectomized control group, Group (3): ovariectomized rats were injected subcutaneously with estradiol for 18 weeks, Group (4): ovariectomized rats were injected intraperitoneally with aluminum chloride (AlCl3) daily for three months, Group (5): ovariectomized rats were injected intraperitoneally with AlCl3 for three months, then, they were injected subcutaneously with estradiol three times weekly for 18 weeks. Hydrogen peroxide (H2O2), malondialdehyde (MDA), total antioxidant capacity (TAC), superoxide dismutase (SOD), catalase (CAT), B cell lymphoma 2 (Bcl-2), brain derived neurotrophic factor (BDNF), acetylcholinesterase (AchE) and acetylcholine (Ach) were determined in brain tissue of all studied groups.
RESULTS: The results showed that brain TAC, SOD activity, Bcl-2 and BDNF levels were decreased significantly due to ovariectomy. Brain H2O2, MDA levels and AchE activity were increased significantly after AlCl3 administration to ovariectomized rats. Brain TAC, Bcl-2, BDNF and Ach levels were decreased significantly as a result of AlCl3 supplementation to ovariectomized rats. Treatment of rats with estradiol produced marked improvement in the most studied biomarkers and this finding was well documented by histological investigation of the brain which showed remarkable improvement in the feature of the neurons in addition to the disappearance of plaques.
CONCLUSIONS: We could conclude that estradiol administration significantly ameliorates the neurodegeneration characteristic of Alzheimer's disease in experimental rat model. This may be attributed to its powerful antioxidant, antiapoptotic, neurotrophic as well as its antiamyloidogenic activities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22165673

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Galantamine tethered hydrogel as a novel therapeutic target for streptozotocin-induced Alzheimer's disease in Wistar rats.

Authors:  Manickam Rajkumar; Murugesan Sakthivel; Kottaisamy Senthilkumar; Ramasundaram Thangaraj; Soundarapandian Kannan
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-04-17

2.  Estrogen inhibits lipid peroxidation after hypoxic-ischemic brain damage in neonatal rats.

Authors:  Hui Zhu; Xiao Han; Dafeng Ji; Guangming Lv; Meiyu Xu
Journal:  Neural Regen Res       Date:  2012-11-05       Impact factor: 5.135

Review 3.  Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease.

Authors:  Andrea Kwakowsky; Michael R Milne; Henry J Waldvogel; Richard L Faull
Journal:  Int J Mol Sci       Date:  2016-12-17       Impact factor: 5.923

4.  The anti-Alzheimer potential of Tamarindus indica: an in vivo investigation supported by in vitro and in silico approaches.

Authors:  Abeer H Elmaidomy; Usama Ramadan Abdelmohsen; Faisal Alsenani; Hanan F Aly; Shams Gamal Eldin Shams; Eman A Younis; Kawkab A Ahmed; Ahmed M Sayed; Asmaa I Owis; Naglaa Afifi; Dalia El Amir
Journal:  RSC Adv       Date:  2022-04-19       Impact factor: 4.036

5.  A strategy to find novel candidate anti-Alzheimer's disease drugs by constructing interaction networks between drug targets and natural compounds in medical plants.

Authors:  Bi-Wen Chen; Wen-Xing Li; Guang-Hui Wang; Gong-Hua Li; Jia-Qian Liu; Jun-Juan Zheng; Qian Wang; Hui-Juan Li; Shao-Xing Dai; Jing-Fei Huang
Journal:  PeerJ       Date:  2018-05-11       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.